Impax Laboratories is a specialty pharmaceutical company that employs its patented controlled-release microencapsulation and tablet technologies in the development and marketing of generic drug products. Impax also develops other generic pharmaceuticals with high barriers of entry for competitors; difficult to source raw materials, complex formulations, etc. Impax also employs its oral drug delivery technologies in the development of enhanced versions (indication and formulation) of existing b...
United States of America
- (24.Mar.2022) Amneal to Present Results From the Pivotal Phase 3 RISE-PD Clinical Trial of IPX-203 at the 2022 American Academy of Neurology Annual Meeting
- (14.Jan.2022) Vanda Pharmaceuticals Settles HETLIOZ Patent Litigation With MSN
- (25.Aug.2021) Amneal Announces Positive Topline Results from Pivotal Phase 3 RISE-PD Clinical Trial of IPX-203 in Patients with Parkinson's Disease Who Experience Motor Fluctuations